The data presented above showing that BCAR3 regulates the cytoskeletal response of invasive breast cancer cells to EGF thus provide a second point of convergence between BCAR3 and intracellular signaling pathways that control tumor cell motility and invasion. This evidence concerns the gene EGF and breast cancer.